HMy2.CIR Cells
545,10 CAD$*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
Renseignements généraux
| Description | The HMy2.CIR cell line was developed through gamma irradiation and subsequent selection for the loss of HLA class I antigen expression from the HMy.2 B lymphoblastoid cell line. This parental cell line is a fast-growing mutant derived from the ARH-77 cell line. HMy2.CIR cells are particularly valuable as hosts for transfected class I major histocompatibility antigen genes, offering a versatile platform for studying antigen presentation and immune response mechanisms. The ARH-77 cell line, from which HMy2.CIR is ultimately derived, is known to be positive for Epstein-Barr nuclear antigen (EBNA+) and Epstein-Barr viral capsid antigen (EBVCA+). Consequently, the HMy2.CIR cell line is also presumed to be EBNA positive. This cell line is characterized by its expression of small amounts of HLA Cw4, but it does not express HLA A or B locus products. This unique antigen expression profile makes HMy2.CIR cells a useful model for immunological research, particularly in the study of HLA class I-restricted antigen processing and presentation. |
|---|---|
| Organisme | Human |
| Tissu | B-Lymphoblast |
| Synonymes | Hmy.2 CIR, HMy2.CIR, C1R |
Caractéristiques
| Âge | 33 years |
|---|---|
| Genre | Female |
| Origine ethnique | Caucasian |
| Morphologie | Lymphoblast |
| Propriétés de croissance | Suspension |
Données réglementaires
| Référence | HMy2.CIR (Cytion catalog number 305126) |
|---|---|
| Niveau de biosécurité | 2 |
| NCBI_Numéro d'identification fiscale | 9606 |
| Cellosaurus - Numéro d'enregistrement | CVCL_3714 |
Données biomoléculaires
Manipulation
| Milieu de culture | IMDM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 25 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 3.024 g/L NaHCO3 (Cytion article number 820800a) |
|---|---|
| Suppléments | Supplement the medium with 10% FBS |
| Repiquage | Gently homogenize the cell suspension in the flask by pipetting up and down, then take a representative sample to determine the cell density per ml. Dilute the suspension to achieve a cell concentration of 1 x 105 cells/ml with fresh culture medium, and aliquot the adjusted suspension into new flasks for further cultivation. |
| Renouvellement des fluides | 2 to 3 times per week |
| Milieu de congélation | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Décongélation et culture des cellules |
|
| Atmosphère d'incubation | 37°C, 5% CO2, humidified atmosphere. |
| Conditions d'expédition | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Conditions d'entreposage | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Contrôle de la qualité et analyse moléculaire
| Stérilité | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificat d'analyse (CoA)
| Numéro de lot | Type de certificat | Date | Numéro de catalogue |
|---|---|---|---|
| 305126-260723 | Certificat d'analyse | 23. May. 2025 | 305126 |
| 305126-080925 | Certificat d'analyse | 05. Dec. 2025 | 305126 |